Laboratorio de Química Industrial, Facultad de Ciencias Químicas, Universidad Autónoma de Nuevo León, Av. Universidad s/n Cd. Universitaria, San Nicolás de los Garza 66455, Nuevo León, Mexico.
Departamento de Microbiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Madero y Dr. Aguirre Pequeño, Col. Mitras Centro, Monterrey 64460, Nuevo León, Mexico.
Molecules. 2023 May 10;28(10):3995. doi: 10.3390/molecules28103995.
is a pathogenic and multidrug-resistant fungus that can infect both immunocompetent and immunocompromised patients, with mortality rates up to 87%. The World Health Organization (WHO) included this fungal species in its first list of 19 priority fungal pathogens, which focused on fungal pathogens that can cause invasive acute and subacute systemic fungal infections. Therefore, there is a growing interest in finding new therapeutic alternatives. In this work, the synthesis of twelve α-aminophosphonates by the microwave-assisted Kabachnik-Fields reaction and twelve α-aminophosphonic acids by a monohydrolysis reaction is reported. All compounds were evaluated by the agar diffusion method as a preliminary screening in comparison with voriconazole, showing inhibition halos for compounds , , , and . The five active compounds in the preliminary tests were evaluated against five strains of following protocol M38-A2 from CLSI. The results showed that these compounds exhibit antifungal activity in the concentration range of 900->900 μg/mL. Cytotoxicity against healthy COS-7 cells was also evaluated by the MTT assay, and it was shown that compound was the least cytotoxic, with a viability of 67.91%, comparable to the viability exhibited by voriconazole (68.55%). Docking studies showed that the possible mechanism of action of the active compounds could be through the inhibition of the enzyme lanosterol-14-alpha-demethylase in an allosteric hydrophobic cavity.
是一种具有致病性和多重耐药性的真菌,可感染免疫功能正常和免疫功能低下的患者,死亡率高达 87%。世界卫生组织(WHO)将该真菌物种列入其首批 19 种优先真菌病原体名单中,该名单重点关注可引起侵袭性急性和亚急性系统性真菌感染的真菌病原体。因此,人们越来越关注寻找新的治疗替代品。在这项工作中,通过微波辅助 Kabachnik-Fields 反应合成了 12 种α-氨基膦酸酯,通过单水解反应合成了 12 种α-氨基膦酸。所有化合物均通过琼脂扩散法进行评估,作为与伏立康唑的初步筛选比较,显示化合物 、 、 、 和 的抑制晕圈。在初步测试中,对五种活性化合物进行了五种 的测试,遵循 CLSI 的 M38-A2 方案。结果表明,这些化合物在 900->900μg/ml 的浓度范围内表现出抗真菌活性。还通过 MTT 测定法评估了对健康 COS-7 细胞的细胞毒性,结果表明化合物 是最具细胞毒性的,其活力为 67.91%,与伏立康唑(68.55%)表现出的活力相当。对接研究表明,活性化合物的可能作用机制可能是通过在变构疏水性腔中抑制酶羊毛甾醇-14-α-去甲基酶。